The TrueBeam Linear Accelerator's RapidArc technology is effective in treating diseases such as breast cancer, prostate cancer, lung, head and neck cancer. It has the ability to target the tumour ...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the Neuro-Oncology Translational Research ...